Merlo-Pich E - Search Results

1

Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.

Spina MG, Merlo-Pich E, Akwa Y, Balducci C, Basso AM, Zorrilla EP, Britton KT, Rivier J, Vale WW, Koob GF. Spina MG, et al. Psychopharmacology (Berl). 2002 Mar;160(2):113-21. doi: 10.1007/s00213-001-0940-y. Epub 2001 Dec 20. Psychopharmacology (Berl). 2002. PMID: 11875628

2

Behavioral effects of central administration of the novel CRF antagonist astressin in rats.

Spina MG, Basso AM, Zorrilla EP, Heyser CJ, Rivier J, Vale W, Merlo-Pich E, Koob GF. Spina MG, et al. Neuropsychopharmacology. 2000 Mar;22(3):230-9. doi: 10.1016/S0893-133X(99)00108-6. Neuropsychopharmacology. 2000. PMID: 10693150

3

Appetite-suppressing effects of urocortin, a CRF-related neuropeptide.

Spina M, Merlo-Pich E, Chan RK, Basso AM, Rivier J, Vale W, Koob GF. Spina M, et al. Science. 1996 Sep 13;273(5281):1561-4. doi: 10.1126/science.273.5281.1561. Science. 1996. PMID: 8703220

4

Corticotropin-releasing factor (CRF) antagonist [D-Phe12,Nle21,38,C alpha MeLeu37]CRF attenuates the acute actions of the highly potent cannabinoid receptor agonist HU-210 on defensive-withdrawal behavior in rats.

Rodríguez de Fonseca F, Rubio P, Menzaghi F, Merlo-Pich E, Rivier J, Koob GF, Navarro M. Rodríguez de Fonseca F, et al. J Pharmacol Exp Ther. 1996 Jan;276(1):56-64. J Pharmacol Exp Ther. 1996. PMID: 8558457

5

The role of CRF in behavioral aspects of stress.

Heinrichs SC, Menzaghi F, Merlo Pich E, Britton KT, Koob GF. Heinrichs SC, et al. Ann N Y Acad Sci. 1995 Dec 29;771:92-104. doi: 10.1111/j.1749-6632.1995.tb44673.x. Ann N Y Acad Sci. 1995. PMID: 8597448 Review.

6

Involvement of hypothalamic corticotropin-releasing factor neurons in behavioral responses to novelty in rats.

Menzaghi F, Heinrichs SC, Merlo-Pich E, Tilders FJ, Koob GF. Menzaghi F, et al. Neurosci Lett. 1994 Feb 28;168(1-2):139-42. doi: 10.1016/0304-3940(94)90435-9. Neurosci Lett. 1994. PMID: 8028766

7

Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis.

Merlo Pich E, Lorang M, Yeganeh M, Rodriguez de Fonseca F, Raber J, Koob GF, Weiss F. Merlo Pich E, et al. J Neurosci. 1995 Aug;15(8):5439-47. doi: 10.1523/JNEUROSCI.15-08-05439.1995. J Neurosci. 1995. PMID: 7643193 Free PMC article.

8

Neurocircuitry targets in ethanol reward and dependence.

Koob GF, Roberts AJ, Schulteis G, Parsons LH, Heyser CJ, Hyytiä P, Merlo-Pich E, Weiss F. Koob GF, et al. Alcohol Clin Exp Res. 1998 Feb;22(1):3-9. Alcohol Clin Exp Res. 1998. PMID: 9514280 Review.

9

Characterization of a 7% carbon dioxide (CO2) inhalation paradigm to evoke anxiety symptoms in healthy subjects.

Poma SZ, Milleri S, Squassante L, Nucci G, Bani M, Perini GI, Merlo-Pich E. Poma SZ, et al. J Psychopharmacol. 2005 Sep;19(5):494-503. doi: 10.1177/0269881105056533. J Psychopharmacol. 2005. PMID: 16166187 Clinical Trial.

10

A two-compartment exploratory model to study anxiolytic/anxiogenic effects of drugs in the rat.

Merlo Pich E, Samanin R. Merlo Pich E, et al. Pharmacol Res. 1989 Sep-Oct;21(5):595-602. doi: 10.1016/1043-6618(89)90201-6. Pharmacol Res. 1989. PMID: 2574443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

119 results

Search Page